Posted on July 24, 2017 by Sitemaster
A newly published study in Clinical Cancer Research has implied the potential development of a completely new and much more accurate way to be able to identify risk for metastatic prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: blood, cell, circulating, count, CTC, megakaryocyte, PSA, tumor | 1 Comment »
Posted on April 12, 2017 by Sitemaster
According to a report on the Reuters web site this morning, an Indian company called Strand Life Sciences that is based in Bengaluru (Bangalore) has just launched (in India) a simple blood test that may be usable to diagnose a whole spectrum of different types of cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: blood, Diagnosis, test | Leave a comment »
Posted on August 11, 2016 by Sitemaster
As some of our older readers will remember, there was a major Phase III clinical trial several years ago (the SELECT trial) designed to study whether taking regular selenium supplements could help to lower risk for a diagnosis of prostate cancer. It didn’t. … READ MORE …
Filed under: Diagnosis, Management, Prevention, Risk | Tagged: blood, nails, risk, selenium | Leave a comment »
Posted on April 9, 2015 by Sitemaster
New data published in the journal Applied Materials and Interfaces (along with media information that should be read with some caution) suggests the possibility of a new way to test for risk of prostate cancer based on the adhesion of citrate-capped gold nanoparticles to biomolecules in truly tiny blood samples. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: blood, Diagnosis, gold, nanoparticles, risk | 1 Comment »
Posted on January 31, 2014 by Sitemaster
Perhaps the most fascinating paper to be presented this year at the Genitourinary Cancers Symposium has to do with blood typing and risk for lethal prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: blood, group, mortality, risk, type | 3 Comments »
Posted on February 4, 2013 by Sitemaster
A recent Japanese paper has suggested that a low white blood cell (neutrophil) count may be an independent predictor of risk for a positive biopsy and a diagnosis of prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: biopsy, blood, cell, count, Diagnosis, neutrophil, risk, white | 8 Comments »
Posted on January 3, 2011 by Sitemaster
According to an Associated Press story that came out this morning, Johnson & Johnson and “Boston scientists” are working together on “A blood test so sensitive that it can spot a single cancer cell lurking among a billion healthy ones.” … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: blood, circulating tumor cells, CTCs, HB-Chip | 10 Comments »
Posted on February 25, 2009 by Sitemaster
Our third report today covers such topics as:
- A positive biopsy risk nomogram for men in New Zealand
- A review of current trends and priorities in surgical technique for radical prostatectomy
- A review of the potential of functional MRI-based systems for the diagnosis of prostate cancer
- Demonstration of a relationship between circulating tumor cells and circulating tumor-associated DNA in blood
- Evaluation of a new, biologically based IMRT treatment planning system … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: biopsy, blood, circulating tumor cells, CTCs, Diagnosis, DNA, functional, IMRT, MRI, New Zealand, nomogram, radical prostatectomy, risk, technique, treatment planning | Leave a comment »
Posted on September 3, 2008 by Sitemaster
A Reuters report issued today quotes US-based researchers as saying that men with elevated levels of calcium in their blood may have a much higher risk of getting fatal prostate cancer than the average man with a diagnosis of prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Treatment | Tagged: blood, calcium, cancer, levels, news, prostate, risk, update | Leave a comment »